Nedaplatin (INN, marketed under the tradename Aqupla) is a platinum-based antineoplastic drug which is used for cancer chemotherapy.

[1] The complex consists of two ammine ligands and the dianion derived from glycolic acid.

Platinum-based drugs are widely employed as antineoplastic agents, especially cisplatin and carboplatin.

Due to issues of their toxicity and number of cisplatin-resistant cancer cells, other platinum derivatives have been developed.

[2] This antineoplastic or immunomodulatory drug article is a stub.